Drawing for CYTARIS

USPTO serial 79266161

CYTARIS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MIDDLETON, BERNICE L
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CYTARIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart diseaseABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 4, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 11, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 11, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 18, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 11, 2020MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Jun 11, 2020ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jun 11, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Jun 11, 2020OP.DOPPOSITION DISMISSED NO. 999999—
May 15, 2020GPNXNOTIFICATION PROCESSED BY IB—
Apr 10, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 20, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 17, 2020OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Mar 17, 2020OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Nov 19, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 30, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 30, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 30, 2019NPUBNOTICE OF PUBLICATION—
Oct 11, 2019ALIEASSIGNED TO LIE—
Oct 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 4, 2019DOCKASSIGNED TO EXAMINER—
Sep 13, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 29, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance